Onychomycosis: Treatment and prevention of recurrence.

Onychomycosis is a fungal nail infection caused by dermatophytes, nondermatophytes, and yeast, and is the most common nail disorder seen in clinical practice. It is an important problem because it may cause local pain, paresthesias, difficulties performing activities of daily living, and impair social interactions. The epidemiology, risk factors, and clinical presentation and diagnosis of onychomycosis were discussed in the first article in this continuing medical education series. In this article, we review the prognosis and response to onychomycosis treatment, medications for onychomycosis that have been approved by the US Food and Drug Administration, and off-label therapies and devices. Methods to prevent onychomycosis recurrences and emerging therapies are also described.

• Publication year

  2019

• Venue

  Journal of American Academy of Dermatology

• Publication date

  2019-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jaad.2018.05.1260PMID 29959962
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Insights About Onychomycosis and Its Treatment: A Consensus.

  2018cited by this paper
• In vitro efficacy of tavaborole topical solution, 5% after penetration through nail polish on ex vivo human fingernails

  2018cited by this paper
• Effect of methylene blue-mediated antimicrobial photodynamic therapy on dentin caries microcosms

  2018cited by this paper
• Laser-assisted Photodynamic Therapy or Laser-assisted Amorolfine Lacquer Delivery for Treatment of Toenail Onychomycosis: An Open-label Comparative Study.

  2018cited by this paper
• Treatment of Dermatophytosis in Elderly, Children, and Pregnant Women

  2017cited by this paper
• Topical antifungal treatment prevents recurrence of toenail onychomycosis following cure

  2017cited by this paper
• Design and optimization of highly-selective, broad spectrum fungal CYP51 inhibitors.

  2017cited by this paper
• In Vitro Human Onychopharmacokinetic and Pharmacodynamic Analyses of ME1111, a New Topical Agent for Onychomycosis

  2017cited by this paper
• In vitro fungicidal effects of methylene blue at 625‐nm

  2017cited by this paper
• Notice of Removal: Ultrasound-enhanced drug delivery for treatment of Onychomycosis

  2017cited by this paper
• Randomized Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy with Short-Pulsed 1,064-nm Neodymium-Doped Yttrium Aluminium Garnet Laser and Amorolfine Nail Lacquer for Onychomycosis

  2017cited by this paper
• A critical review of improvement rates for laser therapy used to treat toenail onychomycosis

  2017cited by this paper
• Clinical presentation of terbinafine‐induced severe liver injury and the value of laboratory monitoring: a Critically Appraised Topic

  2017cited by this paper
• Oral antifungal medication for toenail onychomycosis.

  2017cited by this paper
• Treating onychomycosis with the short‐pulsed 1064‐nm‐Nd:YAG laser: results of a prospective randomized controlled trial

  2017cited by this paper
• The Tetrazole VT-1161 Is a Potent Inhibitor of Trichophyton rubrum through Its Inhibition of T. rubrum CYP51

  2017cited by this paper
• Pilot study to evaluate a plasma device for the treatment of onychomycosis

  2017cited by this paper
• Evaluation of nail lines: Color and shape hold clues

  2016cited by this paper
• An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis*

  2016cited by this paper
• Onychomycosis: Practical Approaches to Minimize Relapse and Recurrence

  2016cited by this paper
• Rapid Treatment of Subungual Onychomycosis Using Controlled Micro Nail Penetration and Terbinafine Solution.

  2016cited by this paper
• Evaluation of the Appearance of Nail Polish Following Daily Treatment of Ex Vivo Human Fingernails With Topical Solutions of Tavaborole or Efinaconazole.

  2016cited by this paper
• In situ production of ROS in the skin by photodynamic therapy as a powerful tool in clinical dermatology.

  2016cited by this paper
• How do we measure efficacy of therapy in onychomycosis: Patient, physician, and regulatory perspectives

  2016cited by this paper
• Long-standing Onychodystrophy in a Young Woman.

  2016cited by this paper
• Onychomycosis of Toenails and Post-hoc Analyses with Efinaconazole 10% Solution Once-daily Treatment: Impact of Disease Severity and Other Concomitant Associated Factors on Selection of Therapy and Therapeutic Outcomes.

  2016cited by this paper
• Laser Therapy for Onychomycosis: Fact or Fiction?

  2015cited by this paper
• In Vitro Nail Penetration of Tavaborole Topical Solution, 5%, Through Nail Polish on Ex Vivo Human Fingernails.

  2015cited by this paper
• A retrospective chart review of the clinical efficacy of Nd:YAG 1064-nm laser for toenail onychomycosis

  2015cited by this paper
• Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail

  2015cited by this paper
• Management of onychomycosis and co-existing tinea pedis.

  2015cited by this paper
• Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.

  2015cited by this paper
• 1,064-nm Diode Laser Therapy of Onychomycosis: Results of a Prospective Open Treatment of 82 Toenails

  2015cited by this paper
• Inhibitory effect of silver nanoparticles mediated by atmospheric pressure air cold plasma jet against dermatophyte fungi.

  2015cited by this paper
• The association of fractional CO2 laser 10.600nm and photodynamic therapy in the treatment of onychomycosis

  2015cited by this paper
• Evaluation of improvement of onychomycosis in HIV‐infected patients after initiation of combined antiretroviral therapy without antifungal treatment

  2015cited by this paper
• VT-1161 Dosed Once Daily or Once Weekly Exhibits Potent Efficacy in Treatment of Dermatophytosis in a Guinea Pig Model

  2015cited by this paper
• Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early.

  2015cited by this paper
• British Association of Dermatologists' guidelines for the management of onychomycosis 2014

  2014cited by this paper
• Oral Therapy for Onychomycosis: An Evidence-Based Review

  2014cited by this paper
• Comparison of the efficacy of long-pulsed Nd:YAG laser intervention for treatment of onychomycosis of toenails or fingernails.

  2014cited by this paper
• Treatment of onychomycosis using the 1 064 nm Nd:YAG laser: a clinical pilot study

  2014cited by this paper
• Penetration of ((14)C)-Efinaconazole Topical Solution, 10%, Does Not Appear to be Influenced by Nail Polish.

  2014cited by this paper
• Toenail onychomycosis treated with a fractional carbon-dioxide laser and topical antifungal cream.

  2014cited by this paper
• Prognostic Factors in Onychomycosis Treatment

  2014cited by this paper
• Design and optimization of highly-selective fungal CYP51 inhibitors.

  2014cited by this paper
• A case of exuberant candidal onychomycosis in a child with hyper IgE syndrome.

  2014cited by this paper
• Lack of efficacy with 1064-nm neodymium:yttrium-aluminum-garnet laser for the treatment of onychomycosis: a randomized, controlled trial.

  2014cited by this paper
• Treatment of onychomycosis using a 1064nm Nd:YAG laser.

  2013cited by this paper
• Fungicidal drugs induce a common oxidative-damage cellular death pathway.

  2013cited by this paper
• Onychomycosis Does Not Always Require Systemic Treatment for Cure: A Trial Using Topical Therapy

  2013cited by this paper
• Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.

  2013cited by this paper
• Systemic Antifungals to Treat Onychomycosis in Children: A Systematic Review

  2013cited by this paper
• Contact-free inactivation of Trichophyton rubrum and Microsporum canis by cold atmospheric plasma treatment.

  2013cited by this paper
• Current and emerging options in the treatment of onychomycosis.

  2013cited by this paper
• Terbinafine in the treatment of dermatophyte toenail onychomycosis: a meta‐analysis of efficacy for continuous and intermittent regimens

  2013cited by this paper
• Prospective efficacy and safety evaluation of laser treatments with real-time temperature feedback for fungal onychomycosis.

  2013cited by this paper
• Treatment of onychomycosis using a submillisecond 1064-nm neodymium:yttrium-aluminum-garnet laser.

  2013cited by this paper
• Sanitization of Contaminated Footwear from Onychomycosis Patients Using Ozone Gas: A Novel Adjunct Therapy for Treating Onychomycosis and Tinea Pedis?

  2013cited by this paper
• Photodynamic therapy with methyl-aminolevulinate can be useful in the management of Scytalidium infections.

  2013cited by this paper
• Evidence-based optimal fluconazole dosing regimen for onychomycosis treatment

  2013cited by this paper
• Effects of laser irradiation on Trichophyton rubrum growth and ultrastructure.

  2012cited by this paper
• Terbinafine

  2012cited by this paper
• A study on the decontamination of insoles colonized by Trichophyton rubrum: effect of terbinafine spray powder 1% and terbinafine spray solution 1%

  2012cited by this paper
• New therapeutic options for onychomycosis

  2012cited by this paper
• Optimization of an infected shoe model for the evaluation of an ultraviolet shoe sanitizer device.

  2012cited by this paper
• A study on the decontamination of insoles colonized by Trichophyton rubrum: effect of terbinafine spray powder 1% and terbinafine spray solution 1%.

  2012cited by this paper
• Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure: some follow-up observations at 270 days.

  2012cited by this paper
• A randomized, placebo‐ and active‐controlled, parallel‐group, multicentre, investigator‐blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis

  2012cited by this paper
• Treating onychomycoses of the toenail: clinical efficacy of the sub-millisecond 1,064 nm Nd: YAG laser using a 5 mm spot diameter.

  2012cited by this paper
• Fusarium solani onychomycosis of the thumbnail coinfected with Pseudomonas aeruginosa: report of two cases

  2011cited by this paper
• Onychomycosis: a proposed revision of the clinical classification.

  2011cited by this paper
• Onychomycosis: Diagnosis and management.

  2011cited by this paper
• Ultrasound‐Mediated Nail Drug Delivery System

  2011cited by this paper
• Cure rate, duration required for complete cure and recurrence rate of onychomycosis according to clinical factors in Korean patients

  2011cited by this paper
• Treatment of refractory fingernail onychomycosis caused by nondermatophyte molds with methylaminolevulinate photodynamic therapy.

  2011cited by this paper
• A new classification system for grading the severity of onychomycosis: Onychomycosis Severity Index.

  2011cited by this paper
• Infection Risk by Dermatophytes During Storage and After Domestic Laundry and Their Temperature-Dependent Inactivation

  2010cited by this paper
• Photodynamic therapy for distal and lateral subungual toenail onychomycosis caused by Trichophyton rubrum: Preliminary results of a single-centre open trial.

  2010cited by this paper
• Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.

  2010cited by this paper
• Treatment of mild, moderate, and severe onychomycosis using 870- and 930-nm light exposure.

  2010cited by this paper
• Disseminated Fusarium infection originating from paronychia in a neutropenic patient: a case report and review of the literature.

  2010cited by this paper
• Itraconazole

  2009cited by this paper
• Prognostic factors for cure following treatment of onychomycosis

  2009cited by this paper
• An Ex Vivo Toe Model Used to Assess Applicators for the Iontophoretic Ungual Delivery of Terbinafine

  2009cited by this paper
• The significance of itraconazole for treatment of fungal infections of skin, nails and mucous membranes

  2009cited by this paper
• Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis.

  2009cited by this paper
• Efficacy of Fluconazole for the Treatment of Onychomycosis

  2009cited by this paper
• Successful treatment of toenail onychomycosis with photodynamic therapy.

  2008cited by this paper
• Review of antifungal therapy and the severity index for assessing onychomycosis: Part I

  2008cited by this paper
• Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?

  2008cited by this paper
• The biochemistry of heme biosynthesis.

  2008cited by this paper
• The effects of laser irradiation on Trichophyton rubrum growth

  2008cited by this paper
• Photodynamic therapy of onychomycosis caused by Trichophyton rubrum.

  2008cited by this paper
• Enhancing the nail permeability of topically applied drugs

  2008cited by this paper
• Onychomycosis: diagnosis and definition of cure.

  2007cited by this paper
• An Antifungal Agent Inhibits an Aminoacyl-tRNA Synthetase by Trapping tRNA in the Editing Site

  2007cited by this paper
• Malassezia furfur onychomycosis in an immunosuppressed liver transplant recipient.

  2007cited by this paper
• Majocchi's granuloma after kidney transplantation.

  2006cited by this paper
• A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.

  2006cited by this paper

• Risk factors for Poor Response to Itraconazole in Onychomycosis Patients: A Prospective, Observational Study in China

  2026cites this paper
• Silver Nanoparticles Loaded Pluronic Hydrogel of Terbinafine Hydrochloride for Treatment of Onychomycosis

  2026cites this paper
• Topical film-forming systems for antifungal delivery: emerging strategies and in-depth evaluation.

  2026cites this paper
• Epidemiological Profile of Onychomycoses at Mohammed V Military Teaching Hospital (HMIMV), Rabat, Morocco, 2024–2025

  2026cites this paper
• Retrospective study of onychomycosis patients treated with ciclopirox 8% HPCH and oral antifungals applying artificial intelligence to electronic health records

  2025cites this paper
• A Double‐Blind Randomised Clinical Trial of Terbinafine‐Nanostructured Lipid Carriers: Should We Anticipate This Strategy for Effective Topical Treatment of Onychomycosis?

  2025cites this paper
• Fungal Nail Infection in Early Infancy: A Case of Subungual Candidal Onychomycosis

  2025cites this paper
• Penetration and Preliminary Efficacy of a Novel Nitric Oxide-Releasing Gel for Onychomycosis

  2025cites this paper
• Analysis of Causative Factors and Potential Predictors of Onychomycosis: A Retrospective Single-Center Study in Poland

  2025cites this paper
• Treatment strategies for controlling antifungal resistance in Candida onychomycosis

  2025cites this paper
• Transfersome enhances nail penetration of antifungal drug and photosensitizer for chemo-photodynamic therapy of onychomycosis in a novel rat model.

  2025cites this paper
• Onychomycosis prevalence etiology and associated factors in women using nail cosmetics attending Mbarara regional referral hospital dermatology clinic Uganda

  2025cites this paper
• Long term efficacy of Nd: Yag laser treatment for onychomycosis

  2025cites this paper
• Fungal detection and elimination based on AIEgens

  2025cites this paper
• Treating onychomycosis in diabetic patients: risk, therapy, and topical opportunity

  2025cites this paper
• Comparative Retrospective Evaluation of the Clinical and Mycological Efficacy of 69% Nitric Acid, 1064 nm Nd:YAG Laser, and Their Combination in the Treatment of Trichophyton rubrum Onychomycosis over a 12-Month Follow-Up

  2025cites this paper
• Superficial fungal infections in patients with diabetes. Is hyperglycemia the only associated factor?

  2025cites this paper
• Hepatic Transaminases Evaluation in Patients with Onychomycosis Treated with Oral Antifungals: A Retrospective Study with 229 Patients.

  2025cites this paper
• Are Antifungal Nail Polish Bottles a Reservoir for Contamination in Patients Treating Onychomycosis?

  2025influential citation
• Hygiene Practices Against Dermatophytic Fungi: A Review of Strategies to Combat Antifungal Resistance

  2025cites this paper
• Onychomycosis in special populations.

  2025cites this paper
• Onicomicosis distrófica total de las 20 uñas. Un caso con síndrome de Down – Reporte de un caso clínico

  2025cites this paper
• Evaluation of safety and efficacy of calcipotriol 0.005% cream versus terbinafine hydrochloride 1% cream in treatment of onychomycosis; a randomized split body comparative pilot study

  2025cites this paper
• Onychomycosis in Diabetics: A Common Infection with Potentially Serious Complications

  2025cites this paper
• Comparative assessment of the onychomycosis phototherapy methods efficacy

  2025cites this paper
• A six-year retrospective study on the causative agents of onychomycosis in China: the emergence of dematiaceous fungi

  2025cites this paper
• Experimental research on fungal inhibition using dissolving microneedles of terbinafine hydrochloride nanoemulsion for beta-1,3-glucanase

  2025cites this paper
• On the mode of anti-C. albicans activity of a bis(benzoxaborole) analogue of Tavaborole

  2024cites this paper
• Onychomycosis in the US Pediatric Population—An Emphasis on Fusarium Onychomycosis

  2024cites this paper
• Exploration of synergistically engineered invasomes of fluconazole incorporated with safranal against onychomycosis for enhanced transungual delivery

  2024cites this paper
• Terbinafine in acrylic polymer for the treatment of onychomycosis in hemodialysis patients: a phase II clinical trial

  2024cites this paper
• Analysis of Dermatovenerological Pathology Among Military Personnel During Outpatient Clinic Admission in Ukraine

  2024cites this paper
• Antifungal Selection for the Treatment of Onychomycosis: Patient Considerations and Outcomes

  2024cites this paper
• Expert Panel Review of Skin and Hair Dermatophytoses in an Era of Antifungal Resistance

  2024cites this paper
• Innovative approaches for onychomycosis treatment: An insight into natural remedies and novel pharmaceutical formulations

  2024cites this paper
• Study of the effect of shock wave from a portable pulsed cold air plasma jet device on inactivation of Trichophyton rubrum in nails

  2024cites this paper
• Treatments for Onychomycosis: A Bibliometric Analysis

  2024cites this paper
• Efficacy of Amorolfine in Onychomycosis Treatment: A Mixed‐Effects Models and Multivariate Logistic Regression Analysis

  2024cites this paper
• Clinical and microbiological characteristics of onychomycosis in a tertiary hospital: a cross-sectional study

  2024cites this paper
• Treatment Options for Onychomycosis: Efficacy, Side Effects, Adherence, Financial Considerations, and Ethics.

  2024cites this paper
• Analysis of clinical characteristics of terbinafine-induced subacute cutaneous lupus erythematosus

  2024cites this paper
• Efficacy of Fractional Versus Fully Ablative CO2 Laser for Distolateral Onychomycosis: Experience With 20 Patients

  2024cites this paper
• Dissolving microneedle to improve transdermal delivery of terbinafine for treatment of onychomycosis

  2024cites this paper
• Efficacy of Laser Therapy in Comparison With Other Methods for the Treatment of Onychomycosis: A Systematic Review and Meta-Analysis

  2024cites this paper
• Ozone Therapy on Fungi that Cause Onychomycosis

  2024cites this paper
• Treatment of onychomycosis in an era of antifungal resistance: Role for antifungal stewardship and topical antifungal agents

  2024cites this paper
• Onychomycosis.

  2024cites this paper
• Two Cases of Superficial Fungal Infection Caused by Non-Albicans Candida Species Manifest Greenish-black Discoloration

  2024cites this paper
• Severe drug eruption from oral terbinafine for mild onychomycosis—A case report from family practice and literature review: “Just an innocent little pill?”

  2024cites this paper
• Nails in older adults

  2024influential citation
• Boron-containing carbonic anhydrases inhibitors.

  2023cites this paper
• Nd:YAG 1064 nm laser treatment for onychomycosis ‐ is it really effective? A prospective assessment for efficiency and factors contributing to response

  2023cites this paper
• Nail Psoriasis & Nail Lichen Planus: Updates on Diagnosis & Management.

  2023cites this paper
• Retrospective Analysis of Liver Enzyme Abnormalities in Patients Prescribed Terbinafine and Itraconazole for Onychomycosis

  2023cites this paper
• Long‐pulsed 1,064‐nm gallium arsenide laser surgical device treatment for improving symptoms of onychomycosis: a comparative analysis

  2023cites this paper
• Novel Henna-Related Naphthazarine Photosensitizers for an Effective Photodynamic Therapy of Onychomycosis.

  2023cites this paper
• Retrospective analysis of onychomycosis prescribing patterns using the medicare part D prescribers database 2016–2020

  2023cites this paper
• p53 and MYC-regulated squalene epoxidase as Achilles heel in colorectal cancer

  2023cites this paper
• Linalool-Incorporated Synergistically Engineered Modified Liposomal Nanocarriers for Enhanced Transungual Delivery of Terbinafine against Onychomycosis

  2023cites this paper
• A review of skin disease in military soldiers: challenges and potential solutions

  2023cites this paper
• Siklopiroks olamin topikal pada onikomikosis rekalsitran yang disebabkan Aspergillus spp.: sebuah laporan kasus

  2023cites this paper
• Thermo-Responsive Sol-Gel-Based Nano-Carriers Containing Terbinafine HCl: Formulation, In Vitro and Ex Vivo Characterization, and Antifungal Activity

  2023influential citation
• Weekly Pulse Dosing of Tetracyclines for Treatment of Acne.

  2023cites this paper
• Risk Factors and Treatment Trends for Onychomycosis: A Case–Control Study of Onychomycosis Patients in the All of Us Research Program

  2023influential citation
• Recent drug development and treatments for fungal infections

  2023cites this paper
• Antifungal effect of (R) and (S)-citronellal enantiomers and their predictive mechanism of action on Candida albicans from voriconazole-resistant onychomycoses.

  2023cites this paper
• Isolation of Terbinafine-Resistant Trichophyton rubrum from Onychomycosis Patients Who Failed Treatment at an Academic Center in New York, United States

  2023influential citation
• Evaluation of the heat sensitivity of Trichophyton rubrum and Trichophyton interdigitale

  2023cites this paper
• The First Report of In Vitro Antifungal and Antibiofilm Photodynamic Activity of Tetra-Cationic Porphyrins Containing Pt(II) Complexes against Candida albicans for Onychomycosis Treatment

  2023cites this paper
• Micosis superficiales

  2023cites this paper
• How Effective Are Devices in the Management of Onychomycosis?: A Systematic Review.

  2023cites this paper
• Mycoses superficielles

  2023cites this paper
• Onychomycosis

  2023cites this paper
• Treatment of Superficial Mycoses Using Photodynamic Therapy: A Systematic Review and Meta-Analysis

  2023cites this paper
• Promising onychomycosis treatment with hypericin-mediated photodynamic therapy: case reports.

  2023cites this paper
• Single-Session Fractional CO2 Laser following Urea Occlusion in Management of Onychomycosis: A Pilot Study

  2023cites this paper
• Superficial Dermatophytosis across the World’s Populations: Potential Benefits from Nanocarrier-Based Therapies and Rising Challenges

  2023cites this paper
• Onychogryphosis Is Associated with Dermatologic and Vascular Disease: A Case-Control Study of the All of Us Research Program

  2023cites this paper
• Prognostic factors for mycological cure in patients with onychomycosis caused by Neoscytalidium dimidiatum: A retrospective cohort study

  2023cites this paper
• Dermatophyte Infections Worldwide: Increase in Incidence and Associated Antifungal Resistance

  2023cites this paper
• Nail Society of India (NSI) Recommendations for Pharmacologic Therapy of Onychomycosis

  2023influential citation
• Formulation development and characterization of an antifungal nail patch based on Pistacia atlantica gum for transungual treatment of onychomycosis

  2023cites this paper
• Onychomycosis in Patients with Diabetes Mellitus in Africa: A Global Scoping Review, 2000–2021

  2022cites this paper
• Updated Perspectives on the Diagnosis and Management of Onychomycosis

  2022influential citation
• Phylogeny, Antifungal Susceptibility, and Point Mutations of SQLE Gene in Major Pathogenic Dermatophytes Isolated From Clinical Dermatophytosis

  2022cites this paper
• DNA‐Chip‐basierte Diagnose der Onychomykose und Tinea pedis

  2022cites this paper
• Treatment of Fingernail Onychomycosis with Efinaconazole 10% Solution in a Patient with Scleroderma: A Case Report

  2022cites this paper
• Updated Perspectives on the Diagnosis and Management of Onychomycosis

  2022cites this paper
• Techniques and Applications of Lower Extremity Feminization and Masculinization

  2022cites this paper
• Don’t blame the nails for SARS-CoV-2 hospitalizations and mortality

  2022cites this paper
• Antimicrobials and Resistance Part II: Antifungals, Antivirals, and Antiparasitics.

  2022cites this paper
• Combination Therapy Should Be Reserved as Second-Line Treatment of Onychomycosis: A Systematic Review of Onychomycosis Clinical Trials

  2022cites this paper
• Evaluation of different DNA extraction methods based on steel‐bullet beating for molecular diagnosis of onychomycosis

  2022cites this paper
• Acitretin: Could it be a new therapeutic player in the field of onychomycosis?

  2022cites this paper
• Determination of terbinafine in healthy Chinese human plasma using a simple and fast LC-MS/MS method and its application to a bioequivalence study.

  2022cites this paper
• DNA chip‐based diagnosis of onychomycosis and tinea pedis

  2022cites this paper
• Optimal diagnosis and management of common nail disorders

  2022cites this paper
• Onychomycosis: Recommendations for Diagnosis, Assessment of Treatment Efficacy, and Specialist Referral. The CONSONANCE Consensus Project

  2022cites this paper
• Risk of fetal malformation, spontaneous abortion, and adverse pregnancy outcomes after gestational terbinafine exposure: a systematic review

  2022cites this paper
• Appraisal of selected ethnomedicinal plants as alternative therapies against onychomycosis: Evaluation of synergy and time-kill kinetics

  2022cites this paper